These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 220888)
1. Effects of the oral converting enzyme inhibitor SQ 14225 in experimental high output failure. Williams GM; Davis JO; Freeman RH; DeForrest JM; Seymour AA; Rowe BP Am J Physiol; 1979 Jun; 236(6):F541-5. PubMed ID: 220888 [TBL] [Abstract][Full Text] [Related]
2. Effects of the oral converting enzyme inhibitor, SQ 14225, in a model of low cardiac output in dogs. Freeman RH; Davis JO; Williams GM; DeForrest JM; Seymour AA; Rowe BP Circ Res; 1979 Oct; 45(4):540-5. PubMed ID: 225056 [TBL] [Abstract][Full Text] [Related]
3. Role of the renin-angiotensin system in the regulation of aldosterone biosynthesis and arterial pressure during sodium deficiency. McCaa RE Circ Res; 1977 May; 40(5 Suppl 1):I157-62. PubMed ID: 870226 [TBL] [Abstract][Full Text] [Related]
4. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs. McCaa RE; Gillespie JB Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226 [TBL] [Abstract][Full Text] [Related]
5. [An experimental study on the effects of the chronic administration of an angiotensin converting enzyme inhibitor (captopril) on blood pressure and the renin-angiotensin-aldosterone system (author's transl)]. Goto A Nihon Naibunpi Gakkai Zasshi; 1980 Jun; 56(6):868-83. PubMed ID: 6997093 [TBL] [Abstract][Full Text] [Related]
6. Angiotensin II blockade and the functions of the renin-angiotensin system. Davis JO; Freeman RH; Watkins BE; Stephens GA; Williams GM Prog Biochem Pharmacol; 1976; 12():1-15. PubMed ID: 798202 [TBL] [Abstract][Full Text] [Related]
7. [Renin and aldosterone secretion under converting enzyme inhibition]. Nakamura K Nihon Naibunpi Gakkai Zasshi; 1983 Aug; 59(8):1099-116. PubMed ID: 6141075 [TBL] [Abstract][Full Text] [Related]
8. Effects of SQ 14,225, an orally active inhibitor of angiotensin-converting enzyme on blood pressure, heart rate and plasma renin activity of conscious normotensive dogs. Harris DN; Heran CL; Goldenberg HJ; High JP; Laffan RJ; Rubin B; Antonaccio MJ; Goldberg ME Eur J Pharmacol; 1978 Oct; 51(4):345-9. PubMed ID: 213295 [TBL] [Abstract][Full Text] [Related]
9. [Effects of angiotensin converting enzyme inhibitor SQ 14,225 on the blood pressure, renin-angiotensin-aldosterone system and renal function in patients with malignant hypertension (author's transl)]. Shionoiri H; Uneda S; Tochikubo O; Ohonishi T; Harada J; Sesoko S; Goto E; Fujishima S; Kaneko Y Nihon Jinzo Gakkai Shi; 1980 Jan; 22(1):13-22. PubMed ID: 6247528 [No Abstract] [Full Text] [Related]
10. Effects of angiotensin I converting enzyme inhibitor (SQ 14,225) on the responses of blood pressure and steroid hormone to angiotensin II and ACTH infusion in hypertensive subjects. Ueda Y; Honda M; Hatano M Jpn Circ J; 1982 Mar; 46(3):267-73. PubMed ID: 6278173 [TBL] [Abstract][Full Text] [Related]
11. The renin-angiotensin-aldosterone system in congestive failure in conscious dogs. Watkins L; Burton JA; Haber E; Cant JR; Smith FW; Barger AC J Clin Invest; 1976 Jun; 57(6):1606-17. PubMed ID: 180056 [TBL] [Abstract][Full Text] [Related]
12. Effects of angiotensin I converting enzyme inhibitor (SQ 14225) on control of aldosterone. Eguchi T; Saito I; Nakamura R; Yasui T; Saruta T Acta Endocrinol (Copenh); 1980 Jun; 94(2):213-20. PubMed ID: 6251687 [No Abstract] [Full Text] [Related]
13. Treatment of drug-resistant hypertension with minoxidil or angiotensin-converting enzyme inhibitor: blood pressure, renin, aldosterone, and electrolyte responses. Baer L; Radichevich I; Williams GS J Cardiovasc Pharmacol; 1980; 2 Suppl 2():S206-16. PubMed ID: 6156357 [TBL] [Abstract][Full Text] [Related]
15. Chronic blockade of angiotensin II formation during sodium deprivation. Hall JE; Guyton AC; Smith MJ; Coleman TG Am J Physiol; 1979 Dec; 237(6):F424-32. PubMed ID: 391063 [TBL] [Abstract][Full Text] [Related]
16. Systemic effects of angiotensin III in conscious dogs during acute double blockade of the renin-angiotensin-aldosterone-system. Gammelgaard I; Wamberg S; Bie P Acta Physiol (Oxf); 2006 Oct; 188(2):129-38. PubMed ID: 16948800 [TBL] [Abstract][Full Text] [Related]
17. The renin-angiotensin-aldosterone system and catecholamines in chronic congestive heart failure. Effect of angiotensin I converting enzyme inhibitor SQ 14225 (Captopril). Kubo S; Nishioka A; Nishimura H; Sonotani N; Takatsu T Jpn Circ J; 1980 Jun; 44(6):427-37. PubMed ID: 6995635 [No Abstract] [Full Text] [Related]
18. Effects of chronic administration of captopril on blood pressure and the renin-angiotensin-aldosterone system in normotensive rats. Ishii M; Goto A; Kimura K; Hirata Y; Yamakado M; Takeda T; Murao S Jpn Heart J; 1983 Jul; 24(4):623-31. PubMed ID: 6358579 [TBL] [Abstract][Full Text] [Related]
19. Effects of prolonged and brief infusions of noradrenaline on arterial pressure and on the plasma concentrations of active renin, angiotensin II, aldosterone and potassium. Casals-Stenzel J; Tree M; Brown JJ; Fraser R; Lever AF; Millar JA; Morton JJ; Robertson JI; Reid JL; Hamilton C J Hypertens; 1983 Jun; 1(1):27-35. PubMed ID: 6397510 [TBL] [Abstract][Full Text] [Related]
20. Renin--angiotensin antagonists and the regulation of blood pressure. Samuels AI; Miller ED; Fray JC; Haber E; Barger AC Fed Proc; 1976 Nov; 35(13):2512-20. PubMed ID: 185095 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]